Logo image
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression
Journal article   Open access   Peer reviewed

A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression

Michael D Weiss, Eric A Macklin, Zachary Simmons, Angela S Knox, David J Greenblatt, Nazem Atassi, Michael Graves, Nicholas Parziale, Johnny S Salameh, Colin Quinn, …
Neurology, Vol.86(16), pp.1474-1481
04/19/2016
DOI: 10.1212/WNL.0000000000002507
PMCID: PMC4836879
PMID: 26911633
url
https://doi.org/10.1212/WNL.0000000000002507View
Published (Version of record) Open Access

Abstract

To determine the safety and tolerability of mexiletine in a phase II double-blind randomized controlled trial of sporadic amyotrophic lateral sclerosis (SALS).
Muscle Cramp - physiopathology Voltage-Gated Sodium Channel Blockers - pharmacokinetics Amyotrophic Lateral Sclerosis - physiopathology Follow-Up Studies Humans Mexiletine - pharmacokinetics Middle Aged Mexiletine - therapeutic use Male Treatment Outcome Postural Balance - drug effects Amyotrophic Lateral Sclerosis - drug therapy Disease Progression Dose-Response Relationship, Drug Mexiletine - adverse effects Voltage-Gated Sodium Channel Blockers - therapeutic use Female Muscle Cramp - drug therapy Voltage-Gated Sodium Channel Blockers - adverse effects

Details

Metrics

Logo image